Maddocks, K. J., Ruppert, A. S., Lozanski, G., Heerema, N. A., Zhao, W., Abruzzo, L., . . . Woyach, J. A. (2015). Etiology of Ibrutinib Discontinuation and Outcomes in Chronic Lymphocytic Leukemia Patients. JAMA Oncol.
Chicago Stili AlıntıMaddocks, Kami J., et al. "Etiology of Ibrutinib Discontinuation and Outcomes in Chronic Lymphocytic Leukemia Patients." JAMA Oncol 2015.
MLA AlıntıMaddocks, Kami J., et al. "Etiology of Ibrutinib Discontinuation and Outcomes in Chronic Lymphocytic Leukemia Patients." JAMA Oncol 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..